Extension of the life span in patients with Werner syndrome.
Yokote
Koutaro
K
Saito
Yasushi
Y
D000328:Adult; D002869:Chromosome Aberrations; D018450:Disease Progression; D005808:Genes, Recessive; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008017:Life Expectancy / Q000639:trends*; D008875:Middle Aged; D000077205:Pioglitazone; D016615:Telomere / Q000187:drug effects; D035341:Telomeric Repeat Binding Protein 2 / Q000187:drug effects / Q000235:genetics; D045162:Thiazolidinediones / Q000627:therapeutic use; D015854:Up-Regulation / Q000187:drug effects; D014898:Werner Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D035341:Telomeric Repeat Binding Protein 2; D045162:Thiazolidinediones; D000077205:Pioglitazone